膵臓癌由来腫瘍オルガノイドおよび線維芽細胞の新鮮組織からの樹立
6.7K 回視聴
•
5 件の引用
•
07:31 分
•
2023年5月26日
DOI :10.3791/65229-v
2023年5月26日
•6.7K 回視聴
Jesús Frutos Díaz-Alejo*1,2,3,4 , Simon April-Monn*5 , Marina Cihova6 , Verona Buocikova6 , Jorge Villalón López1,3 , Maria Urbanova6 , Carmen G. Lechuga7 , Miroslav Tomas6,8 , Peter Dubovan6,8 , Bárbara Luna Sánchez3 , Sonia Camaño Páez3 , Alfonso Sanjuanbenito2,9 , Eduardo Lobo9 , Estefanía Romio de la Heras10 , Carmen Guerra2,7 , Carolina de la Pinta11 , Emma Barreto Melian1,2 , Mercedes Rodríguez Garrote1,2 , Alfredo Carrato1,2,4 , Laura Ruiz-Cañas3,12,13 , Bruno Sainz, Jr.2,3,12,13 , Ana Torres3 , Bozena Smolkova6 , Julie Earl1,2,3
1Molecular Epidemiology and Predictive Tumor Markers Group, Area 3, Ramón y Cajal Health Research Institute (IRYCIS), 2The Biomedical Research Network in Cancer (CIBERONC), 3Biobank and Biomodels Platform (PT20/0045), ISCIII research and development platforms in biomedicine and health sciences, BioBank Hospital Ramón y Cajal-IRYCIS, Spanish National Biobanks Network (ISCIII Biobank Register No. B.0000678), Ramón y Cajal Health Research Institute (IRYCIS), 4Faculty of Medicine, University of Alcalá de Henares, 5Institute of Tissue Medicine and Pathology, University of Bern, 6Department of Molecular Oncology, Cancer Research Institute, Biomedical Research Center of the Slovak Academy of Sciences, 7Experimental Oncology, Molecular Oncology Program, Centro Nacional de Investigaciones Oncológicas (CNIO), 8Department of Surgical Oncology, National Cancer Institute, Slovak Medical University, 9Pancreatic and Biliopancreatic Surgery Unit, Hospital Universitario Ramón y Cajal, 10Department of Pathology, Hospital Universitario Ramón y Cajal, 11Department of Radiation Oncology, Hospital Universitario Ramón y Cajal, 12Department of Cancer, Instituto de Investigaciones Biomédicas “Alberto Sols” (IIBM), 13Cancer Stem Cell and Fibroinflammatory Group, Chronic Diseases and Cancer, Area 3, IRYCIS
* These authors contributed equally
腫瘍オルガノイドは、がん研究と個別化医療へのアプローチに革命をもたらしました。これらは、臨床的に関連性のある腫瘍モデルであり、研究者は診療所で腫瘍の一歩先を行くことができます。このプロトコルは、新鮮な膵臓腫瘍組織サンプルおよび膵臓腺癌起源の患者由来の異種移植片から腫瘍オルガノイドを確立します。
Chapters in this video
0:00
Introduction
1:59
Fresh Primary Tumor Tissue Processing to Establish Tumor Organoids and Primary Fibroblasts
Related Videos
著作権 © 2026 MyJoVE Corporation. 無断転載を禁じます。